MKS InstrumentsMKSI
About: MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue, and the majority of its revenue is earned in the United States.
Employees: 10,200
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
890% more call options, than puts
Call options by funds: $208M | Put options by funds: $21M
65% more repeat investments, than reductions
Existing positions increased: 178 | Existing positions reduced: 108
30% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 54
3% more funds holding
Funds holding: 394 [Q2] → 404 (+10) [Q3]
5.27% less ownership
Funds ownership: 106.13% [Q2] → 100.86% (-5.27%) [Q3]
21% less capital invested
Capital invested by funds: $9.32B [Q2] → $7.37B (-$1.95B) [Q3]
50% less funds holding in top 10
Funds holding in top 10: 6 [Q2] → 3 (-3) [Q3]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Needham James Ricchiuti 60% 1-year accuracy 69 / 115 met price target | 30%upside $156 | Buy Reiterated | 15 Jan 2025 |
Goldman Sachs | 7%upside $128 | Neutral Maintained | 10 Jan 2025 |
Citigroup Atif Malik 54% 1-year accuracy 27 / 50 met price target | 8%upside $130 | Buy Upgraded | 6 Jan 2025 |
Morgan Stanley Joseph Moore 67% 1-year accuracy 38 / 57 met price target | 25%upside $150 | Overweight Maintained | 16 Dec 2024 |
JP Morgan Peter Peng 80% 1-year accuracy 8 / 10 met price target | 21%upside $145 | Overweight Initiated | 13 Dec 2024 |
Financial journalist opinion
Based on 7 articles about MKSI published over the past 30 days
